MYO myomo.com: מכפיל P/S עתידי

Myomo, Inc. (MYO) ensures reliability through strict control over the final assembly of exoskeletons while partially outsourcing electronics. This chart of the company's expected P/S clearly confirms market expectations, where the metric is maintained at 1.10. Business growth is based on Medicare reimbursement approvals and stable cash flow, as well as the recognition of robotic systems by insurance funds and the medical community.

The forward P/S ratio determines the market value of an asset relative to expected annual revenue, allowing investors to assess the extent of overpayment for future cash flows. By analyzing the forward P/S of the company, one can compare sales growth rates with the capitalization of Myomo, Inc., whose unique reputation in the field of robotic prosthetics justifies a premium valuation due to the high value of restoring patient mobility.